Navnath Gavande
Wayne State University
H-index: 20
North America-United States
Top articles of Navnath Gavande
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract 1713 Shaping antiviral strategies with potent and selective non-covalent SARS-CoV-2 papain-like protease inhibitors | Journal of Biological Chemistry | Abdullah Al-Homoudi Hariprased Aruri Dineshsinha Chauhan Olivia Haskin Jacob Tartamella | 2024/3/1 |
Abstract A027: Development of small molecule inhibitors of the Ku-DNA interaction: Impacts on NHEJ, DDR signaling, optimizing genome editing technologies, and therapeutic … | Cancer Research | John J Turchi Pamela L Mendoza-Munoz Pamela S VanderVere-Carozza Navnath S Gavande Joseph R Dynlacht | 2024/1/9 |
Abstract B020: Targeting the DNA damage response sensor Replication Protein A for first in class cancer therapy | Cancer Research | Katherine Pawelczak Pamela VanderVere-Carozza Matthew Jordon Navnath Gavande John Turchi | 2024/1/9 |
Novel Ku-DNA binding inhibitors impact on the cellular and in vivo DNA damage response to radio- and radiomimetic-therapy | Cancer Research | Pamela L Mendoza-Munoz Dineshsinha Chauhan Navnath S Gavande Joseph R Dynlacht Joy E Garrett | 2024/3/22 |
Development of substituted oxindole derivatives as a Ku-targeted DNA-PK inhibitors for cancer therapy | Cancer Research | Dineshsinha Chauhan Pamela L Mendoza-Munoz Narva Deshwar Kushwaha Hariprasad Aruri John J Turchi | 2024/3/22 |
Compositions and methods relating to inhibitors of pro-inflammatory factors for treatment of cancer | 2024/3/19 | ||
OPEN ACCESS EDITED BY | Community Series-Extremophiles: Microbial Genomics and Taxogenomics, Volume II | José Luis Losada Asier Gonzalez-Artetxe Yousri Elghoul Júlio A Costa JA Costa | 2023/11/22 |
Replication protein a (rpa)-dna interaction inhibitors | 2023/2/23 | ||
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy | Ketki Bhise Navnath S Gavande Arun K Iyer | 2023/9/1 | |
Targeting the epidermal growth factor receptor with molecular degraders: State-of-the-art and future opportunities | Pritam Maity Joydeep Chatterjee Kiran T Patil Sahil Arora Madhurendra K Katiyar | 2023/2/22 | |
Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes | Cancer Immunology, Immunotherapy | Prahlad Parajuli Rayna Rosati Hirva Mamdani Robert E Wright III Zahin Hussain | 2023/5 |
Identification of novel inhibitors targeting KRAS-SOS1 interactions by structure-based drug design | Biophysical Journal | Neel A Patel Timothy Hasse Evan Malin Jeremy M Kelm Navnath Gavande | 2023/2/10 |
Abstract B052: Small molecule RPA inhibitors abrogate the ATR kinase signaling pathway | Molecular Cancer Therapeutics | Matthew R Jordan Diana Ainembabazi Pamela S VanderVere-Carozza Navnath S Gavande Katherine S Pawelczak | 2023/12/1 |
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy | Jeremy M Kelm Deepti S Pandey Evan Malin Hussein Kansou Sahil Arora | 2023/3/30 | |
Benzene fused pyrimidine-based derivatives and their biological properties | Jeremy M Kelm Hariprasad Aruri Prasanth R Nyalapatla Navnath S Gavande | 2023/1/1 | |
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks | NAR cancer | Pamela L Mendoza-Munoz Navnath S Gavande Pamela S VanderVere-Carozza Katherine S Pawelczak Joseph R Dynlacht | 2023/3/1 |
Abstract B068: Modulation of the DNA damage response by novel Ku-DNA binding inhibitors enhances cellular effects of DNA-double strand break inducing agents | Molecular Cancer Therapeutics | Pamela L Mendoza-Munoz Dineshsinha Chauhan Navnath S Gavande John J Turchi | 2023/12/1 |
Nanomedicine approaches to reduce cytokine storms in severe infections | Mohd Ahmar Rauf Maryam Nisar Hosam Abdelhady Navnath Gavande Arun K Iyer | 2022/11/1 | |
Recent advances in the development of non-PIKKs targeting small molecule inhibitors of DNA double-strand break repair | Jeremy M Kelm Amirreza Samarbakhsh Athira Pillai Pamela S VanderVere-Carozza Hariprasad Aruri | 2022/4/6 | |
Ku-DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks | European Journal of Cancer | P Mendoza-Munoz NS Gavande PS VanderVere-Carozza KS Pawelczak JR Dynlacht | 2022/10/1 |
